vulnerability
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT
High
Summary
This CISA advisory details a vulnerability in the Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT, specifically version 0x0110_v1.1.0. The device is susceptible to unauthorized interception of sensitive health data via Bluetooth communication, allowing an attacker within range to obtain glucose measurement values. CISA recommends mitigation strategies to minimize the risk of exploitation, including network segmentation and secure remote access methods.
Summary written automatically in our own words from the original article, which belongs to its publisher and remains the reference. It may contain errors. Sources & data